SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123683
Filing Date
2022-04-27
Accepted
2022-04-27 16:25:54
Documents
12
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d276871ddef14a.htm DEF 14A 468423
2 GRAPHIC g2768711a.jpg GRAPHIC 6967
3 GRAPHIC g2768711b.jpg GRAPHIC 1379
4 GRAPHIC g2768711c.jpg GRAPHIC 1124
5 GRAPHIC g2768711d.jpg GRAPHIC 1700
6 GRAPHIC g2768711e.jpg GRAPHIC 2102
7 GRAPHIC g2768711f.jpg GRAPHIC 2090
8 GRAPHIC g2768712a.jpg GRAPHIC 1549
9 GRAPHIC g2768712b.jpg GRAPHIC 1415
10 GRAPHIC g2768712c.jpg GRAPHIC 949
11 GRAPHIC g2768712d.jpg GRAPHIC 867
12 GRAPHIC g276871g41a47.jpg GRAPHIC 16766
  Complete submission text file 0001193125-22-123683.txt   521824
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40288 | Film No.: 22859993
SIC: 2834 Pharmaceutical Preparations